Another report by Badder et al., in 2018 evaluated the ETA-ADAs development in 218 patients with JIA, and they mentioned that only 0.9% of the patients presented ETA-ADAs, but ADAs serum levels were only slightly above the lower limit of detection of the ELISA test, which was not significant for their study. Here, AGPS is linked to juvenile idiopathic arthritis.